(Q38433829)

3 September 2017

Survivin expression is associated with bladder cancer presence, stage, progression, and mortality (English)

1 reference

3 September 2017

1 reference

6

Yair Lotan

1 reference

3 September 2017

3

Pierre I Karakiewicz

1 reference

3 September 2017

1

Shahrokh F Shariat

1 reference

3 September 2017

5

Arthur I Sagalowsky

1 reference

3 September 2017

2

Raheela Ashfaq

1 reference

3 September 2017

Osamah Saeedi

4

1 reference

PubMed ID

17311310

3 September 2017

language of work or name

English

0 references

publication date

1 March 2007

1 reference

3 September 2017

1 reference

3 September 2017

109

1 reference

3 September 2017

1106-1113

1 reference

3 September 2017

6

1 reference

Trends in the leading causes of death in the United States, 1970-2002.

3 September 2017

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22521

7 January 2021

Apoptosis in the pathogenesis and treatment of disease

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22521

7 January 2021

Apoptosis and chemotherapy for bladder cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22521

7 January 2021

Association of p53 and p21 expression with clinical outcome in patients with carcinoma in situ of the urinary bladder

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22521

7 January 2021

p53, p21, pRB, and p16 expression predict clinical outcome in cystectomy with bladder cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22521

7 January 2021

A survivin gene signature predicts aggressive tumor behavior

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22521

7 January 2021

Survivin, versatile modulation of cell division and apoptosis in cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22521

7 January 2021

Urine detection of survivin and diagnosis of bladder cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22521

7 January 2021

Urine detection of survivin is a sensitive marker for the noninvasive diagnosis of bladder cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22521

7 January 2021

Survivin mRNA copy number in bladder washings predicts tumor recurrence in patients with superficial urothelial cell carcinomas.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22521

7 January 2021

Tumor Content of the Antiapoptosis Molecule Survivin and Recurrence of Bladder Cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22521

7 January 2021

Survivin expression is associated with features of biologically aggressive prostate carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22521

7 January 2021

Immunohistochemical localization and semi-quantitation of hepatic tamoxifen-DNA adducts in rats exposed orally to tamoxifen

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22521

7 January 2021

Assessment of HER-2/neu Status in Breast Cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22521

7 January 2021

Lymphovascular invasion is a pathological feature of biologically aggressive disease in patients treated with radical prostatectomy

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22521

7 January 2021

Lymphovascular invasion is independently associated with overall survival, cause-specific survival, and local and distant recurrence in patients with negative lymph nodes at radical cystectomy

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22521

7 January 2021

Discrepancy between clinical and pathologic stage: impact on prognosis after radical cystectomy

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22521

7 January 2021

Radical cystectomy in the treatment of invasive bladder cancer: long-term results in 1,054 patients.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22521

7 January 2021

Quantitative analysis of survivin mRNA expression in urine and tumor tissue of bladder cancer patients and its potential relevance for disease detection and prognosis.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22521

7 January 2021

Expression of a murine homologue of the inhibitor of apoptosis protein is related to cell proliferation

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22521

7 January 2021

Expression of survivin and apoptotic biomarkers in benign prostatic hyperplasia.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22521

7 January 2021

Analysis of human transcriptomes.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22521

7 January 2021

A novel anti-apoptosis gene, survivin, expressed in cancer and lymphoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22521

7 January 2021

Mitochondrial survivin inhibits apoptosis and promotes tumorigenesis.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22521

7 January 2021

Nuclear or cytoplasmic expression of survivin: what is the significance?

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22521

7 January 2021

Identifiers

DOI

10.1002/CNCR.22521

1 reference

3 September 2017

1 reference

PubMed ID

17311310